Yoshimi Nabe

Toyama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Diffuse Large B-cell Lymphoma with PKM2 and HK2 Expression Presenting with Lactic Acidosis and Hypoglycemia Consistent with the Warburg Effect.

Diffuse Large B-cell Lymphoma with PKM2 and HK2 Expression Presenting with Lactic Acidosis and Hypoglycemia Consistent with the Warburg Effect.

Journal: Internal medicine (Tokyo, Japan)

Published: June 28, 2026

Large B-cell Lymphoma With IRF4 Rearrangement in the Elderly.

Large B-cell Lymphoma With IRF4 Rearrangement in the Elderly.

Journal: Cureus

Published: January 22, 2026

Optimizing bone health in lymphoma survivors: denosumab superiority to alendronate for R-CHOP-like therapy (the DENOSULY phase III randomized controlled trial).

Optimizing bone health in lymphoma survivors: denosumab superiority to alendronate for R-CHOP-like therapy (the DENOSULY phase III randomized controlled trial).

Journal: Haematologica

Published: January 19, 2026

Antiapoptotic BCL2 family proteins BCL-XL and MCL1 as factors predicting resistance against venetoclax plus azacitidine for patients with newly diagnosed acute myelogenous leukemia.

Antiapoptotic BCL2 family proteins BCL-XL and MCL1 as factors predicting resistance against venetoclax plus azacitidine for patients with newly diagnosed acute myelogenous leukemia.

Journal: PloS one

Published: October 14, 2025

Effectiveness and safety of ibrutinib for steroid-dependent/refractory chronic graft-versus-host disease: a single-center analysis

Effectiveness and safety of ibrutinib for steroid-dependent/refractory chronic graft-versus-host disease: a single-center analysis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: September 03, 2025

Drug-induced sarcoidosis-like reaction due to dasatinib in the lung of a patient with chronic myeloid leukemia

Drug-induced sarcoidosis-like reaction due to dasatinib in the lung of a patient with chronic myeloid leukemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: June 04, 2025

Successful Re-administration and Extended Dosing of Brentuximab Vedotin Monotherapy for Relapsed Anaplastic Large Cell Lymphoma in a Vulnerable Patient.

Successful Re-administration and Extended Dosing of Brentuximab Vedotin Monotherapy for Relapsed Anaplastic Large Cell Lymphoma in a Vulnerable Patient.

Journal: Cureus

Published: May 12, 2025

Dermatopathic lymphadenopathy in chronic skin graft-versus-host disease

Dermatopathic lymphadenopathy in chronic skin graft-versus-host disease

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 05, 2025

Successful 30-Day Nirmatrelvir/Ritonavir Treatment of a Patient Who Developed Multi-relapsed COVID-19 After Receiving R-CHOP Against Follicular Lymphoma.

Successful 30-Day Nirmatrelvir/Ritonavir Treatment of a Patient Who Developed Multi-relapsed COVID-19 After Receiving R-CHOP Against Follicular Lymphoma.

Journal: Cureus

Published: February 14, 2025

Pre-transplant blinatumomab and/or inotuzumab ozogamicin therapy for relapsed/refractory acute lymphoblastic and B/myeloid mixed phenotype acute leukemia in adults.

Pre-transplant blinatumomab and/or inotuzumab ozogamicin therapy for relapsed/refractory acute lymphoblastic and B/myeloid mixed phenotype acute leukemia in adults.

Journal: Leukemia research

Published: November 20, 2024

Effect of COVID-19 on Pulmonary Function in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.

Effect of COVID-19 on Pulmonary Function in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: November 19, 2024

Complete response using the EZH2 inhibitor tazemetostat against multiple relapsed follicular lymphoma in the leukemic phase.

Complete response using the EZH2 inhibitor tazemetostat against multiple relapsed follicular lymphoma in the leukemic phase.

Journal: International cancer conference journal

Published: June 18, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026